Abeona Therapeutics (ABEO) announced the appointment of Mohamad Tabrizi as Senior Vice President, Chief Business Officer. In this role, Mr. Tabrizi will lead the Company’s corporate strategy and business development functions, as well as drive operating efficiency for the Company. Tabrizi transitions to Abeona from the venture capital sector, where he served as a General Partner and Managing Director at Pandect Bioventures
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABEO:
- Abeona Therapeutics’ Strategic Advancements and Growing Demand Justify Buy Rating
- Abeona Therapeutics announces new treatment center for Zevaskyn in Texas
- Abeona Therapeutics: Promising Growth with ZEVASKYN’s Market Expansion and Strategic Advancements
- Abeona Therapeutics announces first patient treatment with ZEVASKYN
- Abeona Therapeutics reports employee inducement grants